2018 tables: Institutions - corporate

The 2018 tables are based on Nature Index data from 1 January 2017 to 31 December 2017.

Table criteria

# Institution Share 2016 Share 2017 Count 2017 Change in Adjusted Share 2016-2017*
1 AstraZeneca plc, United Kingdom (UK) 31.19 29.83 128 -5.7%
2 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 15.72 16.17 66 1.3%
3 Unilever, United Kingdom (UK) 1.86 2.46 18 30.3%
4 Johnson Matthey (JM), United Kingdom (UK) 2.02 2.12 13 3.1%
5 Earlham Institute (EI), United Kingdom (UK) 1.01 1.95 11 90.3%
6 Anglo American plc, United Kingdom (UK) 2.71 1.64 7 -40.4%
7 BP plc, United Kingdom (UK) 1.16 1.52 10 28.9%
8 Oxford Instruments, United Kingdom (UK) 0.53 1.51 5 181.4%
9 Oxford BioMedica (UK) Ltd., United Kingdom (UK) 1.22 2 N/A
10 Rio Tinto plc, United Kingdom (UK) 0.85 1.01 3 17.2%
11 Bluewater Bio International (BWB), United Kingdom (UK) 1.00 1 N/A
12 Almac Group, United Kingdom (UK) 0.82 1 N/A
13 BAE Systems, United Kingdom (UK) 0.59 0.68 2 14.1%
14 PragmatIC Printing Limited, United Kingdom (UK) 0.63 1 N/A
15 Scottish Water, United Kingdom (UK) 0.29 0.60 2 105.3%
16 Kromek Group plc, United Kingdom (UK) 0.56 1 N/A
17 Cambridge Display Technology Ltd., United Kingdom (UK) 0.18 0.50 1 171.1%
17 GlaxoSmithKline R&D Ltd., United Kingdom (UK) 1.85 0.50 2 -73.4%
17 Concept Life Sciences, United Kingdom (UK) 0.50 1 N/A
18 Ludger Ltd., United Kingdom (UK) 0.36 0.43 1 18.4%
19 FlexEnable Ltd., United Kingdom (UK) 0.13 0.40 1 215.4%
19 Silixa Ltd., United Kingdom (UK) 0.40 1 N/A
20 Nanoforce Technology Limited, United Kingdom (UK) 0.38 2 N/A
21 M Squared Lasers, United Kingdom (UK) 0.38 1 N/A
22 IQE plc, United Kingdom (UK) 0.44 0.37 2 -19.0%
23 kMatrix Ltd., United Kingdom (UK) 0.38 0.33 1 -12.4%
24 Albumedix Ltd., United Kingdom (UK) 0.09 0.32 2 248.5%
25 Global Phasing Limited, United Kingdom (UK) 0.06 0.32 3 463.4%
26 Kymab Limited, United Kingdom (UK) 0.18 0.32 4 69.2%
27 UVO3 Ltd., United Kingdom (UK) 0.30 1 N/A
28 First Light Fusion Ltd., United Kingdom (UK) 0.02 0.29 2 1,337.4%
28 QinetiQ Group plc, United Kingdom (UK) 0.24 0.29 2 20.7%
29 Isomerase Therapeutics Ltd., United Kingdom (UK) 0.07 0.28 1 308.1%
30 Crescendo Biologics Ltd., United Kingdom (UK) 0.10 0.25 1 146.4%
30 Palaeocreations, United Kingdom (UK) 0.13 0.25 1 97.1%
30 Oxford Nanopore Technologies Ltd., United Kingdom (UK) 0.43 0.25 1 -42.8%
30 Ingenza Ltd., United Kingdom (UK) 0.25 1 N/A
30 Three Cliffs Geomechanical Analysis Limited, United Kingdom (UK) 0.25 1 N/A
30 QuantuMDx UK, United Kingdom (UK) 0.25 1 N/A
30 Leaf Systems International Limited, United Kingdom (UK) 0.25 1 N/A
30 Isogenica Ltd., United Kingdom (UK) 0.25 1 N/A
30 Meggitt PLC, United Kingdom (UK) 0.25 1 N/A
31 Horizon Discovery Ltd., United Kingdom (UK) 0.20 0.24 1 14.9%
32 ATDBio Ltd., United Kingdom (UK) 0.23 2 N/A
33 LMK Thermosafe Ltd., United Kingdom (UK) 0.22 1 N/A
34 Ipsos MORI, United Kingdom (UK) 0.21 1 N/A
35 Infineum International Ltd., United Kingdom (UK) 0.20 1 N/A
35 Triskel Marine Ltd., United Kingdom (UK) 0.20 1 N/A
35 De La Rue, United Kingdom (UK) 0.20 1 N/A
35 Bio-Optika, United Kingdom (UK) 0.20 1 N/A
35 Kernow Analytical Technology Limited (KAT), United Kingdom (UK) 0.20 1 N/A
36 Avacta Group Plc, United Kingdom (UK) 0.20 2 N/A
37 Biotica Technology Ltd., United Kingdom (UK) 0.20 1 N/A
38 MIP Diagnostics Ltd., United Kingdom (UK) 0.18 2 N/A
39 Fluorogenics Ltd., United Kingdom (UK) 0.18 1 N/A
39 Biogene Ltd., United Kingdom (UK) 0.18 1 N/A
40 Bristol Industrial and Research Associates Limited (BIRAL), United Kingdom (UK) 0.17 1 N/A
40 ADAS UK Ltd., United Kingdom (UK) 0.05 0.17 1 245.0%
40 rdscientific, United Kingdom (UK) 0.43 0.17 1 -62.1%
40 TgK Scientific Limited, United Kingdom (UK) 0.17 1 N/A
40 FindMyPast Newspaper Archive Limited, United Kingdom (UK) 0.17 1 N/A
40 Sellafield Ltd., United Kingdom (UK) 0.13 0.17 1 31.4%
40 Malvern Instruments Ltd., United Kingdom (UK) 0.20 0.17 1 -17.9%
40 Rigare, United Kingdom (UK) 0.17 1 N/A
41 SSBN Limited, United Kingdom (UK) 0.14 0.16 2 8.0%
42 Labman Automation Ltd., United Kingdom (UK) 0.15 1 N/A
42 BMT Group Ltd., United Kingdom (UK) 0.15 1 N/A
43 OMass Technologies Limited, United Kingdom (UK) 0.15 1 N/A
44 Abzena PLC, United Kingdom (UK) 0.15 1 N/A
45 Cambridge Quantum Computing Limited (CQC), United Kingdom (UK) 0.15 1 N/A
46 Cairn Energy PLC, United Kingdom (UK) 0.20 0.14 1 -29.6%
46 Orthox Ltd., United Kingdom (UK) 0.14 1 N/A
46 Molecular Discovery Ltd., United Kingdom (UK) 0.14 1 N/A
46 Mass Spectrometry Instruments (MSI) Ltd., United Kingdom (UK) 0.14 1 N/A
47 Cambustion Ltd., United Kingdom (UK) 0.14 2 N/A
48 JEOL (UK) Ltd., United Kingdom (UK) 0.13 2 N/A
49 Getech, United Kingdom (UK) 0.11 0.13 1 10.9%
49 Ricardo Energy and Environment, United Kingdom (UK) 0.25 0.13 1 -50.7%
49 Memsstar Limited, United Kingdom (UK) 0.13 1 N/A
49 Genomics plc, United Kingdom (UK) 0.13 1 N/A
49 Oxford Policy Management Limited (OPM), United Kingdom (UK) 0.13 1 N/A
49 Micro Materials Limited, United Kingdom (UK) 0.13 1 N/A
49 Tullow Oil plc, United Kingdom (UK) 0.13 1 N/A
50 Capita plc, United Kingdom (UK) 0.58 0.11 3 -81.1%
51 GEO Specialty Chemicals, Inc., United Kingdom (UK) 0.69 0.11 1 -84.0%
51 LGC Limited, United Kingdom (UK) 1.09 0.11 1 -89.9%
51 Aylesbury Automation Limited, United Kingdom (UK) 0.11 1 N/A
51 Bioscript Group Limited, United Kingdom (UK) 0.11 1 N/A
52 Synome Ltd., United Kingdom (UK) 0.18 0.10 1 -45.8%
52 Cairn Research Ltd., United Kingdom (UK) 0.10 1 N/A
52 Deloitte MCS Limited, United Kingdom (UK) 0.10 1 N/A
53 P1vital, United Kingdom (UK) 0.10 1 N/A
54 Autolus, Ltd., United Kingdom (UK) 0.09 1 N/A
55 Anaerobic Analytics Ltd., United Kingdom (UK) 0.09 1 N/A
55 Nanolayers Research Computing Ltd., United Kingdom (UK) 0.09 1 N/A
55 Top-Hole Site Studies Limited, United Kingdom (UK) 0.09 1 N/A
56 Cancer Research Technology Ltd. (CRT), United Kingdom (UK) 0.06 0.09 2 48.8%
57 The Henry Stewart Group, United Kingdom (UK) 0.14 0.08 1 -42.5%
57 Cello Health Insight plc, United Kingdom (UK) 0.08 1 N/A
57 Dr. Reddy's Laboratories (UK) Ltd., United Kingdom (UK) 0.08 1 N/A
57 XAAR plc, United Kingdom (UK) 0.08 1 N/A
57 Nikaworks Ltd., United Kingdom (UK) 0.08 1 N/A
57 Fracture Systems Limited, United Kingdom (UK) 0.08 1 N/A
57 Atmospheric Chemistry Services, United Kingdom (UK) 0.08 1 N/A
58 Agta Aid, United Kingdom (UK) 0.08 1 N/A
58 Veramed Ltd., United Kingdom (UK) 0.08 1 N/A
58 PTx Solutions Ltd., United Kingdom (UK) 0.08 1 N/A
58 BenevolentAI Limited, United Kingdom (UK) 0.08 1 N/A
59 Aspinall Consultants Limited, United Kingdom (UK) 0.07 2 N/A
60 Manchester Nanomaterials Limited, United Kingdom (UK) 0.13 0.07 1 -43.7%
60 DougalEARTH Ltd., United Kingdom (UK) 0.05 0.07 1 47.8%
60 Folium Optics Limited, United Kingdom (UK) 0.07 1 N/A
60 Vernalis plc, United Kingdom (UK) 0.74 0.07 1 -90.5%
61 Smart Dx Consulting Ltd., United Kingdom (UK) 0.07 1 N/A
61 Magnus Life Science, United Kingdom (UK) 0.07 1 N/A
62 Storm Therapeutics Ltd., United Kingdom (UK) 0.06 1 N/A
63 Rolls-Royce plc, United Kingdom (UK) 0.29 0.06 3 -78.8%
63 WS Atkins plc, United Kingdom (UK) 0.29 0.06 3 -78.8%
64 PhoreMost Ltd., United Kingdom (UK) 0.06 1 N/A
65 Ilika plc, United Kingdom (UK) 0.06 1 N/A
65 Abaco Systems Limited, United Kingdom (UK) 0.06 1 N/A
65 PathCelerate Ltd., United Kingdom (UK) 0.06 1 N/A
66 hVIVO Services Limited, United Kingdom (UK) 0.05 1 N/A
67 Cellular Therapeutics Ltd., United Kingdom (UK) 0.03 0.05 1 97.1%
67 Immunocore Limited, United Kingdom (UK) 0.14 0.05 1 -63.9%
68 Base4 Innovation Ltd., United Kingdom (UK) 0.05 1 N/A
68 Black Bawks Data Science Ltd., United Kingdom (UK) 0.05 1 N/A
69 Finden Ltd., United Kingdom (UK) 0.04 1 N/A
70 Environmental Research Group Oxford Limited (ERGO), United Kingdom (UK) 0.04 1 N/A
71 Analytical Services International Ltd., United Kingdom (UK) 0.04 1 N/A
71 Statsconsultancy Ltd., United Kingdom (UK) 0.04 1 N/A
72 Desktop Genetics Ltd., United Kingdom (UK) 0.03 1 N/A
72 Cambridge Consultants Ltd., United Kingdom (UK) 0.03 1 N/A
73 Westwood Global Energy Group, United Kingdom (UK) 0.03 1 N/A
74 Serco Group plc, United Kingdom (UK) 0.03 2 N/A
75 BGResearch Ltd., United Kingdom (UK) 0.03 1 N/A
76 Genomics England Ltd., United Kingdom (UK) 0.05 0.03 2 -47.2%
77 Pharmidex, United Kingdom (UK) 0.20 0.03 1 -87.0%
78 Bio Nano Consulting, United Kingdom (UK) 0.05 0.03 1 -45.8%
79 Sequani Limited, United Kingdom (UK) 0.02 1 N/A
80 Canterbury Archaeological Trust Ltd., United Kingdom (UK) 0.08 0.02 1 -70.9%
81 Pharmatics Limited, United Kingdom (UK) 0.02 1 N/A
82 Oncimmune Limited, United Kingdom (UK) 0.02 0.02 1 -3.2%
83 Delosis Limited, United Kingdom (UK) 0.02 1 N/A
84 Engineered Biodesign Limited, United Kingdom (UK) 0.02 1 N/A
85 Repositive Limited, United Kingdom (UK) 0.01 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.